Exact Mass: 281.1991

Exact Mass Matches: 281.1991

Found 212 metabolites which its exact mass value is equals to given mass value 281.1991, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

Cycloheximide

2,6-PIPERIDINEDIONE, 4-(2-(3,5-DIMETHYL-2-OXOCYCLOHEXYL)-2-HYDROXYETHYL)-, (1S-(1.ALPHA.(S*),3.ALPHA.,5.BETA.))-

C15H23NO4 (281.1627)


Cycloheximide appears as colorless crystals. Used as a fungicide and as a anticancer drug. (EPA, 1998) Cycloheximide is a dicarboximide that is 4-(2-hydroxyethyl)piperidine-2,6-dione in which one of the hydrogens attached to the carbon bearing the hydroxy group is replaced by a 3,5-dimethyl-2-oxocyclohexyl group. It is an antibiotic produced by the bacterium Streptomyces griseus. It has a role as a bacterial metabolite, a protein synthesis inhibitor, a neuroprotective agent, an anticoronaviral agent and a ferroptosis inhibitor. It is a member of piperidones, a piperidine antibiotic, an antibiotic fungicide, a dicarboximide, a secondary alcohol and a cyclic ketone. It is functionally related to a piperidine-2,6-dione. Cycloheximide is a natural product found in Streptomyces, Streptomyces griseus, and Streptomyces pulveraceus with data available. Antibiotic substance isolated from streptomycin-producing strains of Streptomyces griseus. It acts by inhibiting elongation during protein synthesis. A dicarboximide that is 4-(2-hydroxyethyl)piperidine-2,6-dione in which one of the hydrogens attached to the carbon bearing the hydroxy group is replaced by a 3,5-dimethyl-2-oxocyclohexyl group. It is an antibiotic produced by the bacterium Streptomyces griseus. D004791 - Enzyme Inhibitors > D011500 - Protein Synthesis Inhibitors D000890 - Anti-Infective Agents > D000935 - Antifungal Agents C254 - Anti-Infective Agent > C514 - Antifungal Agent Origin: Microbe; SubCategory_DNP: Alkaloids derived from lysine, Piperidine alkaloids relative retention time with respect to 9-anthracene Carboxylic Acid is 0.773 relative retention time with respect to 9-anthracene Carboxylic Acid is 0.776 relative retention time with respect to 9-anthracene Carboxylic Acid is 0.777 [Raw Data] CBA53_Cycloheximid_pos_50eV.txt [Raw Data] CBA53_Cycloheximid_pos_20eV.txt [Raw Data] CBA53_Cycloheximid_pos_10eV.txt [Raw Data] CBA53_Cycloheximid_pos_40eV.txt [Raw Data] CBA53_Cycloheximid_pos_30eV.txt

   

Xanomeline tartrate

5-[4-(hexyloxy)-1,2,5-thiadiazol-3-yl]-1-methyl-1,2,3,6-tetrahydropyridine

C14H23N3OS (281.1562)


Same as: D06330 Xanomeline, as an effective and selective muscarinic type 1 and type 4 (M1/M4) receptor agonist, increases neuronal excitability. Xanomeline can be used for the research of neurological disorders, such as schizophrenia[1][2].

   

colestipol

Tetraethylenepentamine crosslinked with epichlorohydrin

C11H28ClN5O (281.1982)


It is used as a food additive . C - Cardiovascular system > C10 - Lipid modifying agents > C10A - Lipid modifying agents, plain > C10AC - Bile acid sequestrants D019995 - Laboratory Chemicals > D007475 - Ion Exchange Resins > D000837 - Anion Exchange Resins D057847 - Lipid Regulating Agents > D000960 - Hypolipidemic Agents D009676 - Noxae > D000963 - Antimetabolites D001697 - Biomedical and Dental Materials D064449 - Sequestering Agents

   

XANOMELINE

XANOMELINE

C14H23N3OS (281.1562)


D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents > D010277 - Parasympathomimetics D018377 - Neurotransmitter Agents > D018678 - Cholinergic Agents > D018679 - Cholinergic Agonists C78272 - Agent Affecting Nervous System > C47796 - Cholinergic Agonist D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs Same as: D06330 Xanomeline, as an effective and selective muscarinic type 1 and type 4 (M1/M4) receptor agonist, increases neuronal excitability. Xanomeline can be used for the research of neurological disorders, such as schizophrenia[1][2].

   

phentolamine

phentolamine

C17H19N3O (281.1528)


C - Cardiovascular system > C04 - Peripheral vasodilators > C04A - Peripheral vasodilators > C04AB - Imidazoline derivatives V - Various > V03 - All other therapeutic products > V03A - All other therapeutic products > V03AB - Antidotes C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C72900 - Adrenergic Antagonist D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D018674 - Adrenergic Antagonists D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents Phentolamine is a potent, selective and orally active α1 adrenergic and α2 adrenergic receptor antagonist. Phentolamine can be used for the research of erectile dysfunction[1][2][3].

   

Phentolamine

3-[(4,5-dihydro-1H-imidazol-2-ylmethyl)(4-methylphenyl)amino]phenol

C17H19N3O (281.1528)


Phentolamine is only found in individuals that have used or taken this drug. It is a nonselective alpha-adrenergic antagonist. It is used in the treatment of hypertension and hypertensive emergencies, pheochromocytoma, vasospasm of raynaud disease and frostbite, clonidine withdrawal syndrome, impotence, and peripheral vascular disease (PubChem). Phentolamine produces its therapeutic actions by competitively blocking alpha-adrenergic receptors (primarily excitatory responses of smooth muscle and exocrine glands), leading to a muscle relaxation and a widening of the blood vessels. This widening of the blood vessels results in a lowering of blood pressure. The action of phentolamine on the alpha adrenergic receptors is relatively transient and the blocking effect is incomplete. The drug is more effective in antagonizing responses to circulating epinephrine and/or norepinephrine than in antagonizing responses to mediator released at the adrenergic nerve ending. Phentolamine also stimulates β-adrenergic receptors and produces a positive inotropic and chronotropic effect on the heart and increases cardiac output. C - Cardiovascular system > C04 - Peripheral vasodilators > C04A - Peripheral vasodilators > C04AB - Imidazoline derivatives V - Various > V03 - All other therapeutic products > V03A - All other therapeutic products > V03AB - Antidotes C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C72900 - Adrenergic Antagonist D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D018674 - Adrenergic Antagonists D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents Phentolamine is a potent, selective and orally active α1 adrenergic and α2 adrenergic receptor antagonist. Phentolamine can be used for the research of erectile dysfunction[1][2][3].

   

8-hydroxymirtazapine

5-methyl-2,5,19-triazatetracyclo[13.4.0.0²,⁷.0⁸,¹³]nonadeca-1(19),8,10,12,15,17-hexaen-17-ol

C17H19N3O (281.1528)


8-hydroxymirtazapine is a metabolite of mirtazapine. Mirtazapine (Remeron, Avanza, Zispin) is a noradrenergic and specific serotonergic antidepressant (NaSSA) which was introduced by Organon International in the United States in 1990 and is used primarily in the treatment of depression. It is also commonly used as an anxiolytic, hypnotic, antiemetic, and appetite stimulant. Structurally, mirtazapine can also be classified as a tetracyclic antidepressant (TeCA). (Wikipedia)

   

Alverine

N-Ethyl-3-phenyl-N-(3-phenylpropyl)-1-propanamine

C20H27N (281.2143)


Alverine is a smooth muscle relaxant. Smooth muscle is a type of muscle that is not under voluntary control; it is the muscle present in places such as the gut and uterus. Alverine acts directly on the muscle in the gut, causing it to relax. This prevents the muscle spasms which occur in the gut in conditions such as irritable bowel syndrome and diverticular disease. It is used to relieve cramps or spasms of the stomach and intestines. It is also useful in treating irritable bowel syndrome (IBS) and similar conditions. It can also be used to help relieve period pain. Alverine is formulated as the citrate salt (5982-87-6). A - Alimentary tract and metabolism > A03 - Drugs for functional gastrointestinal disorders > A03A - Drugs for functional gastrointestinal disorders D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents > D010276 - Parasympatholytics C78272 - Agent Affecting Nervous System > C66880 - Anticholinergic Agent

   

Diphenylpyraline

1-Methyl-4-hydroxypiperidine benzhydryl ether

C19H23NO (281.178)


Diphenylpyraline is an antihistamine. Antihistamines used in the treatment of allergy act by competing with histamine for H 1-receptor sites on effector cells. Antihistamines prevent, but do not reverse, responses mediated by histamine alone. Antihistamines antagonize, in varying degrees, most of the pharmacological effects of histamine, including urticaria and pruritus. R - Respiratory system > R06 - Antihistamines for systemic use > R06A - Antihistamines for systemic use > R06AA - Aminoalkyl ethers C308 - Immunotherapeutic Agent > C29578 - Histamine-1 Receptor Antagonist Diphenylpyraline is a potent histamine H1?receptor antagonist. Diphenylpyraline acts as an orally active antihistamine agent?with antimuscarinic and antiallergic effects. Diphenylpyraline can be used for the research of allergic diseases, including rhinitis and hay fever, and pruritic skin disorders et.al[1].

   

Methyl 15-cyanopentadecanoate

Methyl 15-cyanopentadecanoic acid

C17H31NO2 (281.2355)


Methyl 15-cyanopentadecanoate is a nitrile ester that has been isolated from the fresh pods of Moringa oleifera (horseradish tree). Methyl 15-cyanopentadecanoate is found in fats and oils. Constituent of the leaves of Moringa oleifera (horseradish tree). Methyl 15-cyanopentadecanoate is found in fats and oils, herbs and spices, and green vegetables.

   

mirtazapine-N-oxide

5-methyl-2,5λ⁵,19-triazatetracyclo[13.4.0.0²,⁷.0⁸,¹³]nonadeca-1(15),8,10,12,16,18-hexaen-5-one

C17H19N3O (281.1528)


mirtazapine-N-oxide is a metabolite of mirtazapine. Mirtazapine (Remeron, Avanza, Zispin) is a noradrenergic and specific serotonergic antidepressant (NaSSA) which was introduced by Organon International in the United States in 1990 and is used primarily in the treatment of depression. It is also commonly used as an anxiolytic, hypnotic, antiemetic, and appetite stimulant. Structurally, mirtazapine can also be classified as a tetracyclic antidepressant (TeCA). (Wikipedia)

   

Terodiline

N-Tert-butyl-3,3-diphenyl-1-methylpropylamine

C20H27N (281.2143)


Terodiline belongs to the class of organic compounds known as diphenylmethanes. Diphenylmethanes are compounds containing a diphenylmethane moiety, which consists of a methane wherein two hydrogen atoms are replaced by two phenyl groups. Terodiline is considered to be a practically insoluble (in water) and relatively neutral molecule. G - Genito urinary system and sex hormones > G04 - Urologicals > G04B - Urologicals > G04BD - Drugs for urinary frequency and incontinence D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents > D010276 - Parasympatholytics C78281 - Agent Affecting Musculoskeletal System > C29696 - Muscle Relaxant C78272 - Agent Affecting Nervous System > C29698 - Antispasmodic Agent D002317 - Cardiovascular Agents > D002121 - Calcium Channel Blockers D000077264 - Calcium-Regulating Hormones and Agents D049990 - Membrane Transport Modulators

   

1-(Naphthalen-2-yl)-2-(pyrrolidin-1-yl)pentan-1-one

1-(Naphthalen-2-yl)-2-(pyrrolidin-1-yl)pentan-1-one

C19H23NO (281.178)


   

11-Maleimidoundecanoic acid

11-(2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)undecanoic acid

C15H23NO4 (281.1627)


   

3-{4-[2-Hydroxy-3-(propan-2-ylamino)propoxy]phenyl}propanoic acid

3-(4-{2-hydroxy-3-[(propan-2-yl)amino]propoxy}phenyl)propanoic acid

C15H23NO4 (281.1627)


   

Cycloheximide

4-[2-(3,5-dimethyl-2-oxocyclohexyl)-2-hydroxyethyl]piperidine-2,6-dione

C15H23NO4 (281.1627)


   

Piberaline

1-benzyl-4-(pyridine-2-carbonyl)piperazine

C17H19N3O (281.1528)


   

petroselinate

cis-omega-12-octadecenoic acid

C18H33O2- (281.248)


Petroselinic acid, also known as (6z)-petroselinate or (Z)-6-octadecenoate, is a member of the class of compounds known as long-chain fatty acids. Long-chain fatty acids are fatty acids with an aliphatic tail that contains between 13 and 21 carbon atoms. Petroselinic acid is practically insoluble (in water) and a weakly acidic compound (based on its pKa). Petroselinic acid can be found in a number of food items such as jicama, common salsify, orange bell pepper, and cardoon, which makes petroselinic acid a potential biomarker for the consumption of these food products. Petroselinic acid can be found primarily in blood. Petroselinic acid is a fatty acid that occurs naturally in several animal and vegetable fats and oils. It is a white powder and is commercially available. In chemical terms, petroselinic acid is classified as a monounsaturated omega-12 fatty acid, abbreviated with a lipid number of 18:1 cis-6. It has the formula CH3(CH2)10CH=CH(CH2)4COOH. The term "petroselinic" means related to, or derived from, oil of Petroselinum, parsley. Petroselinic acid is an positional isomer of oleic acid . Petroselinic acid, also known as (6z)-petroselinate or (Z)-6-octadecenoate, is a member of the class of compounds known as long-chain fatty acids. Long-chain fatty acids are fatty acids with an aliphatic tail that contains between 13 and 21 carbon atoms. Petroselinic acid is practically insoluble (in water) and a weakly acidic compound (based on its pKa). Petroselinic acid can be found in a number of food items such as jicama, common salsify, orange bell pepper, and cardoon, which makes petroselinic acid a potential biomarker for the consumption of these food products. Petroselinic acid can be found primarily in blood. Petroselinic acid is a fatty acid that occurs naturally in several animal and vegetable fats and oils. It is a white powder and is commercially available. In chemical terms, petroselinic acid is classified as a monounsaturated omega-12 fatty acid, abbreviated with a lipid number of 18:1 cis-6. It has the formula CH3(CH2)10CH=CH(CH2)4COOH. The term "petroselinic" means related to, or derived from, oil of Petroselinum, parsley. Petroselinic acid is an positional isomer of oleic acid.

   

MCULE-5769297339

MCULE-5769297339

C15H23NO4 (281.1627)


   

CJ 13565

(E)-2-(3,7-Dimethyl-2,6-octadienyl)-4(1H)-quinolinone

C19H23NO (281.178)


   

naphyrone

naphyrone

C19H23NO (281.178)


   

5-amino-3-[(2E)-2-(3,5-dimethyl-2-oxocyclohexylidene)ethyl]-5-oxopentanoic acid

5-amino-3-[(2E)-2-(3,5-dimethyl-2-oxocyclohexylidene)ethyl]-5-oxopentanoic acid

C15H23NO4 (281.1627)


   
   

(E,E,E)-2,4,12-Tetradecatriene-8,10-diynoic acid piperidide

(E,E,E)-2,4,12-Tetradecatriene-8,10-diynoic acid piperidide

C19H23NO (281.178)


   

Tropine nonanoate

Tropine nonanoate

C17H31NO2 (281.2355)


   

6beta-Acetoxy-3alpha-tigloyloxytropane

6beta-Acetoxy-3alpha-tigloyloxytropane

C15H23NO4 (281.1627)


   

(2E,4E,6E,12Z)-3-Methylpropylamide-2,4,6,12-Tetradecatetraene-8,10-diynoic acid

(2E,4E,6E,12Z)-3-Methylpropylamide-2,4,6,12-Tetradecatetraene-8,10-diynoic acid

C19H23NO (281.178)


   

dictylomide A|Dictyolomide A

dictylomide A|Dictyolomide A

C19H23NO (281.178)


   

4-oxo-decanoic acid 2-(2,3-dihydro-1H-imidazol-4-yl)-ethylamide|Nalpha-(4-Oxo-decanoyl)-histamin

4-oxo-decanoic acid 2-(2,3-dihydro-1H-imidazol-4-yl)-ethylamide|Nalpha-(4-Oxo-decanoyl)-histamin

C15H27N3O2 (281.2103)


   

scalusamide B

scalusamide B

C16H27NO3 (281.1991)


   

CHEMBL1192721

CHEMBL1192721

C15H23NO4 (281.1627)


   

Deacetyllycofawcine

Deacetyllycofawcine

C16H27NO3 (281.1991)


   

penibruguieramine A

penibruguieramine A

C16H27NO3 (281.1991)


   

scalusamide A

scalusamide A

C16H27NO3 (281.1991)


A pyrrolidine alkaloid that is a monocarboxylic acid amide obtained by the formal condensation of (8E)-2-methyl-3-oxodec-8-enoic acid with (2R)-pyrrolidin-2-ylmethanol. Isolated from the the cultured broth of the fungus Penicillium citrinum, it exhibits anti-fungal and antibacterial activity.

   

Curcutriolamide

Curcutriolamide

C15H23NO4 (281.1627)


   

SCHEMBL17866868

SCHEMBL17866868

C19H23NO (281.178)


   

8-Hydroxymirtazapine

8-hydroxy Mirtazapine

C17H19N3O (281.1528)


CONFIDENCE standard compound; EAWAG_UCHEM_ID 3712 CONFIDENCE standard compound; INTERNAL_ID 1555

   

MLS001049073-01!4-[(2R)-2-[(1R,3R,5S)-3,5-dimethyl-2-oxocyclohexyl]-2-hydroxyethyl]piperidine-2,6-dione

"MLS001049073-01!4-[(2R)-2-[(1R,3R,5S)-3,5-dimethyl-2-oxocyclohexyl]-2-hydroxyethyl]piperidine-2,6-dione"

C15H23NO4 (281.1627)


   

2-[2-(3,5-dimethyl-2-oxocyclohexyl)-6-oxooxan-4-yl]acetamide

NCGC00380295-01!2-[2-(3,5-dimethyl-2-oxocyclohexyl)-6-oxooxan-4-yl]acetamide

C15H23NO4 (281.1627)


   

4-[2-(3,5-dimethyl-2-oxocyclohexyl)-2-hydroxyethyl]piperidine-2,6-dione

NCGC00169964-06!4-[2-(3,5-dimethyl-2-oxocyclohexyl)-2-hydroxyethyl]piperidine-2,6-dione

C15H23NO4 (281.1627)


   

(E)-1-[2-(hydroxymethyl)pyrrolidin-1-yl]-2-methyldec-8-ene-1,3-dione

NCGC00381317-01!(E)-1-[2-(hydroxymethyl)pyrrolidin-1-yl]-2-methyldec-8-ene-1,3-dione

C16H27NO3 (281.1991)


   

5-amino-3-[(2E)-2-(3,5-dimethyl-2-oxocyclohexylidene)ethyl]-5-oxopentanoic acid

NCGC00380332-01!5-amino-3-[(2E)-2-(3,5-dimethyl-2-oxocyclohexylidene)ethyl]-5-oxopentanoic acid

C15H23NO4 (281.1627)


   

Isocycloheximide

Isocycloheximide

C15H23NO4 (281.1627)


   
   

8-OH-Mirtazapine

8-Hydroxymirtazapine

C17H19N3O (281.1528)


CONFIDENCE standard compound; INTERNAL_ID 1555

   

Dainic Acid A

Dainic Acid A

C15H23NO4 (281.1627)


An L-proline derivative that is L-proline substituted by a carboxymethyl group at position 3 and a (2E)-6-methylhepta-2,5-dien-2-yl group at position 4. It is produced by the red algal Chondria armata.

   

(E)-1-[2-(hydroxymethyl)pyrrolidin-1-yl]-2-methyldec-8-ene-1,3-dione [IIN-based on: CCMSLIB00000846613]

NCGC00381317-01!(E)-1-[2-(hydroxymethyl)pyrrolidin-1-yl]-2-methyldec-8-ene-1,3-dione [IIN-based on: CCMSLIB00000846613]

C16H27NO3 (281.1991)


   

5-amino-3-[(2E)-2-(3,5-dimethyl-2-oxocyclohexylidene)ethyl]-5-oxopentanoic acid [IIN-based: Match]

NCGC00380332-01!5-amino-3-[(2E)-2-(3,5-dimethyl-2-oxocyclohexylidene)ethyl]-5-oxopentanoic acid [IIN-based: Match]

C15H23NO4 (281.1627)


   

2-[2-(3,5-dimethyl-2-oxocyclohexyl)-6-oxooxan-4-yl]acetamide [IIN-based on: CCMSLIB00000845929]

NCGC00380295-01!2-[2-(3,5-dimethyl-2-oxocyclohexyl)-6-oxooxan-4-yl]acetamide [IIN-based on: CCMSLIB00000845929]

C15H23NO4 (281.1627)


   

(E)-1-[2-(hydroxymethyl)pyrrolidin-1-yl]-2-methyldec-8-ene-1,3-dione [IIN-based: Match]

NCGC00381317-01!(E)-1-[2-(hydroxymethyl)pyrrolidin-1-yl]-2-methyldec-8-ene-1,3-dione [IIN-based: Match]

C16H27NO3 (281.1991)


   

2-[2-(3,5-dimethyl-2-oxocyclohexyl)-6-oxooxan-4-yl]acetamide [IIN-based: Match]

NCGC00380295-01!2-[2-(3,5-dimethyl-2-oxocyclohexyl)-6-oxooxan-4-yl]acetamide [IIN-based: Match]

C15H23NO4 (281.1627)


   

4-[2-(3,5-dimethyl-2-oxocyclohexyl)-2-hydroxyethyl]piperidine-2,6-dione [IIN-based: Match]

NCGC00169964-06!4-[2-(3,5-dimethyl-2-oxocyclohexyl)-2-hydroxyethyl]piperidine-2,6-dione [IIN-based: Match]

C15H23NO4 (281.1627)


   

4-Hydroxyoxprenolol

4-Hydroxyoxprenolol

C15H23NO4 (281.1627)


   

Benzenepropanoic acid, 4-[2-hydroxy-3-[(1-methylethyl)amino]propoxy]- (9CI) ASL 8123

Benzenepropanoic acid, 4-[2-hydroxy-3-[(1-methylethyl)amino]propoxy]- (9CI) ASL 8123

C15H23NO4 (281.1627)


   

(6R)-6-methyl-7-((8R,Z)-8-methylhexahydroindolizin-6(5H)-ylidene)heptane-2,3-diol

(6R)-6-methyl-7-((8R,Z)-8-methylhexahydroindolizin-6(5H)-ylidene)heptane-2,3-diol

C17H31NO2 (281.2355)


   

(6R)-6-methyl-7-((8R,Z)-8-methylhexahydroindolizin-6(5H)-ylidene)heptane-3,4-diol

(6R)-6-methyl-7-((8R,Z)-8-methylhexahydroindolizin-6(5H)-ylidene)heptane-3,4-diol

C17H31NO2 (281.2355)


   

(1S,Z)-3-((2R)-5-hydroxy-2-methylhexylidene)-1-methyloctahydro-2H-quinolizin-1-ol

(1S,Z)-3-((2R)-5-hydroxy-2-methylhexylidene)-1-methyloctahydro-2H-quinolizin-1-ol

C17H31NO2 (281.2355)


   

ALVERINE

ALVERINE

C20H27N (281.2143)


A - Alimentary tract and metabolism > A03 - Drugs for functional gastrointestinal disorders > A03A - Drugs for functional gastrointestinal disorders D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents > D010276 - Parasympatholytics C78272 - Agent Affecting Nervous System > C66880 - Anticholinergic Agent

   

diphenylpyraline

Diphenylpyralamine;Diphenylpyraline Hydrochloride;Diphenylpyrilene

C19H23NO (281.178)


R - Respiratory system > R06 - Antihistamines for systemic use > R06A - Antihistamines for systemic use > R06AA - Aminoalkyl ethers C308 - Immunotherapeutic Agent > C29578 - Histamine-1 Receptor Antagonist Diphenylpyraline is a potent histamine H1?receptor antagonist. Diphenylpyraline acts as an orally active antihistamine agent?with antimuscarinic and antiallergic effects. Diphenylpyraline can be used for the research of allergic diseases, including rhinitis and hay fever, and pruritic skin disorders et.al[1].

   

Methyl 15-cyanopentadecanoate

Methyl 15-cyanopentadecanoate

C17H31NO2 (281.2355)


   

Naphyrone 1-naphthyl isomer

Naphyrone 1-naphthyl isomer

C19H23NO (281.178)


   

N-octanoyl histidine

N-octanoyl-histidine

C14H23N3O3 (281.1739)


   

C12:1-HSL

N-(2E-dodecenoyl)-homoserine lactone

C16H27NO3 (281.1991)


   

5-cis-C12-HSL

N-(5Z-dodecenoyl)-homoserine lactone

C16H27NO3 (281.1991)


   

Acrylonitrile, butyl acrylate, methyl methacrylate polymer

Acrylonitrile, butyl acrylate, methyl methacrylate polymer

C15H23NO4 (281.1627)


   

Piberaline

Piberaline

C17H19N3O (281.1528)


C78272 - Agent Affecting Nervous System > C265 - Antidepressant Agent

   

2-methyl-5-(2-methylpropyl)-4-(morpholin-4-ylmethyl)furan-3-carboxylic acid

2-methyl-5-(2-methylpropyl)-4-(morpholin-4-ylmethyl)furan-3-carboxylic acid

C15H23NO4 (281.1627)


   

Pyrovalerone hydrochloride solution

Pyrovalerone hydrochloride solution

C16H24ClNO (281.1546)


   

3-methoxy-3,3-diphenyl-N-prop-2-enylpropan-1-amine

3-methoxy-3,3-diphenyl-N-prop-2-enylpropan-1-amine

C19H23NO (281.178)


   

1,4-dibenzylpiperidin-4-ol

1,4-dibenzylpiperidin-4-ol

C19H23NO (281.178)


   

4,4-Di-tert-butyldiphenylamine

4,4-Di-tert-butyldiphenylamine

C20H27N (281.2143)


   

4,4-DI-TERT-BUTYL-[1,1-BIPHENYL]-2-AMINE

4,4-DI-TERT-BUTYL-[1,1-BIPHENYL]-2-AMINE

C20H27N (281.2143)


   
   

4-(3-Pyridinyl)Phenylboronic Acid Pinacol Ester

4-(3-Pyridinyl)Phenylboronic Acid Pinacol Ester

C17H20BNO2 (281.1587)


   

4-(4-BENZYLPIPERAZIN-1-YLMETHYL)PHENYLAMINE

4-(4-BENZYLPIPERAZIN-1-YLMETHYL)PHENYLAMINE

C18H23N3 (281.1892)


   

4-(3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)pyridine

4-(3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)pyridine

C17H20BNO2 (281.1587)


   

2-Phenylpyridine-4-boronic acid pinacol ester

2-Phenylpyridine-4-boronic acid pinacol ester

C17H20BNO2 (281.1587)


   

Boc-Ser(Bzl)-ol

Boc-Ser(Bzl)-ol

C15H23NO4 (281.1627)


   

2-AMINO-1-(4-METHOXYBENZYL)-4,5,6,7-TETRAHYDRO-1H-INDOLE-3-CARBONITRILE

2-AMINO-1-(4-METHOXYBENZYL)-4,5,6,7-TETRAHYDRO-1H-INDOLE-3-CARBONITRILE

C17H19N3O (281.1528)


   

4-(benzhydryloxymethyl)piperidine

4-(benzhydryloxymethyl)piperidine

C19H23NO (281.178)


   

PIPERAZINE-1-CARBOXYLIC ACID DIPHENYLAMIDE

PIPERAZINE-1-CARBOXYLIC ACID DIPHENYLAMIDE

C17H19N3O (281.1528)


   

tert-butyl 4-(1,2,4-triazol-1-ylmethyl)-1,4-diazepane-1-carboxylate

tert-butyl 4-(1,2,4-triazol-1-ylmethyl)-1,4-diazepane-1-carboxylate

C13H23N5O2 (281.1852)


   

(4-tert-butylphenyl)-piperidin-4-ylmethanone,hydrochloride

(4-tert-butylphenyl)-piperidin-4-ylmethanone,hydrochloride

C16H24ClNO (281.1546)


   

Roxadimate

ethyl 4-[bis(2-hydroxypropyl)amino]benzoate

C15H23NO4 (281.1627)


C1892 - Chemopreventive Agent > C851 - Sunscreen

   

11-Maleimidoundecanoic acid

11-Maleimidoundecanoic acid

C15H23NO4 (281.1627)


   

Methyl 4-{4-[Bis(2-Hydroxyethyl)Amino]Phenyl}Butanoate

Methyl 4-{4-[Bis(2-Hydroxyethyl)Amino]Phenyl}Butanoate

C15H23NO4 (281.1627)


   
   

4-(4-Pyridinyl)phenylboronic acid pinacol ester

4-(4-Pyridinyl)phenylboronic acid pinacol ester

C17H20BNO2 (281.1587)


   

4-(2-PYRIDINYL)PHENYLBORONIC ACID PINACOL ESTER

4-(2-PYRIDINYL)PHENYLBORONIC ACID PINACOL ESTER

C17H20BNO2 (281.1587)


   

DIETHYL 4-ETHYL-1,4-DIHYDRO-2,6-DIMETHYL-3,5-PYRIDINEDICARBOXYLATE

DIETHYL 4-ETHYL-1,4-DIHYDRO-2,6-DIMETHYL-3,5-PYRIDINEDICARBOXYLATE

C15H23NO4 (281.1627)


   

butyl prop-2-enoate,ethyl prop-2-enoate,prop-2-enenitrile

butyl prop-2-enoate,ethyl prop-2-enoate,prop-2-enenitrile

C15H23NO4 (281.1627)


   

cinnamedrine

cinnamedrine

C19H23NO (281.178)


C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C87053 - Adrenergic Agonist

   

(1,2-DIMETHYL-1 H-BENZOIMIDAZOL-5-YL)-(4-METHOXY-BENZYL)-AMINE

(1,2-DIMETHYL-1 H-BENZOIMIDAZOL-5-YL)-(4-METHOXY-BENZYL)-AMINE

C17H19N3O (281.1528)


   

2-(1-benzyl-3-phenylpyrrolidin-3-yl)ethanol

2-(1-benzyl-3-phenylpyrrolidin-3-yl)ethanol

C19H23NO (281.178)


   

Tolperisone hydrochloride

Tolperisone hydrochloride

C16H24ClNO (281.1546)


D018373 - Peripheral Nervous System Agents > D009465 - Neuromuscular Agents C78281 - Agent Affecting Musculoskeletal System > C29696 - Muscle Relaxant D002491 - Central Nervous System Agents

   
   

Ofornine

piperidin-1-yl-[2-(pyridin-4-ylamino)phenyl]methanone

C17H19N3O (281.1528)


C78274 - Agent Affecting Cardiovascular System > C270 - Antihypertensive Agent

   
   

boc-o-benzyl-l-serinol

boc-o-benzyl-l-serinol

C15H23NO4 (281.1627)


   

Bis(4-methylphenyl)[(2S)-2-pyrrolidinyl]methanol

Bis(4-methylphenyl)[(2S)-2-pyrrolidinyl]methanol

C19H23NO (281.178)


   

4-Octyl-N-phenylaniline

4-Octyl-N-phenylaniline

C20H27N (281.2143)


   

TRIETHANOLAMINE ETHOXYLATE

TRIETHANOLAMINE ETHOXYLATE

C12H27NO6 (281.1838)


   

Amino-PEG6-alcohol

Amino-PEG6-alcohol

C12H27NO6 (281.1838)


   

3-Methyl-N-[[[(1R,2R)-2-(4-pentyn-1-yl) cyclopropyl]oxy]carbonyl]-L-Valine

3-Methyl-N-[[[(1R,2R)-2-(4-pentyn-1-yl) cyclopropyl]oxy]carbonyl]-L-Valine

C15H23NO4 (281.1627)


   

pp1

1-(tert-Butyl)-3-(p-tolyl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine

C16H19N5 (281.164)


   

N-octyl-N-phenylaniline

N-octyl-N-phenylaniline

C20H27N (281.2143)


   

2-(1-methyl-1H-pyrazol-3-yl)-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine

2-(1-methyl-1H-pyrazol-3-yl)-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine

C17H20BNO2 (281.1587)


   

N-cyclopentyl-5-(4-ethylphenyl)-2-methylpyrimidin-4-amine

N-cyclopentyl-5-(4-ethylphenyl)-2-methylpyrimidin-4-amine

C18H23N3 (281.1892)


   

Sodium (16,16,16-2H3)hexadecanoate

Sodium (16,16,16-2H3)hexadecanoate

C16H28D3NaO2 (281.241)


   

Benzenamine,N-[(4-butoxyphenyl)methylene]-4-ethyl-

Benzenamine,N-[(4-butoxyphenyl)methylene]-4-ethyl-

C19H23NO (281.178)


   

3-(3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)pyridine

3-(3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)pyridine

C17H20BNO2 (281.1587)


   

N-Phenyl-4-(2,4,4-trimethyl-2-pentanyl)aniline

N-Phenyl-4-(2,4,4-trimethyl-2-pentanyl)aniline

C20H27N (281.2143)


   

1H-Imidazolium, 1-decyl-3-methyl-, thiocyanate

1H-Imidazolium, 1-decyl-3-methyl-, thiocyanate

C15H27N3S (281.1926)


   

4-((2,2-dimethyl-1,3-dioxan-5-yl)methoxy)-2,3,5-trimethylpyridine1-oxide

4-((2,2-dimethyl-1,3-dioxan-5-yl)methoxy)-2,3,5-trimethylpyridine1-oxide

C15H23NO4 (281.1627)


   

N-Benzyl-N-isopropyl-3,5-dimethylbenzamide

N-Benzyl-N-isopropyl-3,5-dimethylbenzamide

C19H23NO (281.178)


   

(4-DIMETHYLAMINO-NAPHTHALEN-1-YLMETHYL)-HYDRAZINE

(4-DIMETHYLAMINO-NAPHTHALEN-1-YLMETHYL)-HYDRAZINE

C17H19N3O (281.1528)


   

2-(4-Benzyl-piperazin-1-yl-methyl)aniline

2-(4-Benzyl-piperazin-1-yl-methyl)aniline

C18H23N3 (281.1892)


   

5-tert-butyl-2-methyl-4-(morpholin-4-ylmethyl)furan-3-carboxylic acid

5-tert-butyl-2-methyl-4-(morpholin-4-ylmethyl)furan-3-carboxylic acid

C15H23NO4 (281.1627)


   

3-(Boc-amino)-3-(4-Methoxyphenyl)-1-propanol

3-(Boc-amino)-3-(4-Methoxyphenyl)-1-propanol

C15H23NO4 (281.1627)


   

Blarcamesine

Blarcamesine

C19H23NO (281.178)


C26170 - Protective Agent > C1509 - Neuroprotective Agent Blarcamesine is an orally bioavailable Sigma-1 receptor agonist and muscarinic receptor modulator, with anticonvulsant, anti-amnesic, neuroprotective and antidepressant properties. Blarcamesine ameliorates neurologic impairments in a mouse model of Rett syndrome[1].

   

Oleate

Oleate

C18H33O2- (281.248)


A C18, long straight-chain monounsaturated fatty acid anion; and the conjugate base of oleic acid, arising from deprotonation of the carboxylic acid group.

   

Mirtazapine N-Oxide

Mirtazapine N-Oxide

C17H19N3O (281.1528)


   

4-[(2R)-2-[(1R,3S,5S)-3,5-dimethyl-2-oxocyclohexyl]-2-hydroxyethyl]piperidine-2,6-dione

4-[(2R)-2-[(1R,3S,5S)-3,5-dimethyl-2-oxocyclohexyl]-2-hydroxyethyl]piperidine-2,6-dione

C15H23NO4 (281.1627)


   

7-butyl-6-(4-methoxyphenyl)-5H-pyrrolo[2,3-b]pyrazine

7-butyl-6-(4-methoxyphenyl)-5H-pyrrolo[2,3-b]pyrazine

C17H19N3O (281.1528)


   

N-[(E)-(4-tert-butylphenyl)methylideneamino]pyridine-2-carboxamide

N-[(E)-(4-tert-butylphenyl)methylideneamino]pyridine-2-carboxamide

C17H19N3O (281.1528)


   

3-Acetyl-5-hydroxy-4,5-dimethyl-1-octyl-2-pyrrolone

3-Acetyl-5-hydroxy-4,5-dimethyl-1-octyl-2-pyrrolone

C16H27NO3 (281.1991)


   

4-[N-(4,5-dihydro-1H-imidazol-2-ylmethyl)-4-methylanilino]phenol

4-[N-(4,5-dihydro-1H-imidazol-2-ylmethyl)-4-methylanilino]phenol

C17H19N3O (281.1528)


   

2-Methoxy-1-(1-methyl-2-benzimidazolyl)-1-phenylethanamine

2-Methoxy-1-(1-methyl-2-benzimidazolyl)-1-phenylethanamine

C17H19N3O (281.1528)


   

8-Hydroxymirtazapine, (R)-

8-Hydroxymirtazapine, (R)-

C17H19N3O (281.1528)


   

2-{[(1-propyl-1H-benzimidazol-2-yl)methyl]amino}phenol

2-{[(1-propyl-1H-benzimidazol-2-yl)methyl]amino}phenol

C17H19N3O (281.1528)


   

2-[2-(3,5-Dimethyl-2-oxo-cyclohexyl)-6-oxo-tetrahydro-pyran-4yl]-acetamide

2-[2-(3,5-Dimethyl-2-oxo-cyclohexyl)-6-oxo-tetrahydro-pyran-4yl]-acetamide

C15H23NO4 (281.1627)


   

Elaidate

Elaidate

C18H33O2- (281.248)


A long-chain fatty acid anion that is the conjugate base of elaidic acid; shown to exert detrimental effects on mitochondrial lipid composition and function.

   

trans-Vaccenate

trans-Vaccenate

C18H33O2- (281.248)


   

cis-Vaccenate

cis-Vaccenate

C18H33O2- (281.248)


   

Octadecenoate

Octadecenoate

C18H33O2- (281.248)


   

7-methylisodomoic acid A

7-methylisodomoic acid A

C15H23NO4 (281.1627)


   

Octadec-11-enoate

Octadec-11-enoate

C18H33O2- (281.248)


   

N-[3-[(4-Aminobutyl)amino]propyl]-3,4-dihydroxybenzamide

N-[3-[(4-Aminobutyl)amino]propyl]-3,4-dihydroxybenzamide

C14H23N3O3 (281.1739)


   

(2S)-2-[[2-[(1R,2S)-3-oxo-2-[(Z)-pent-2-enyl]cyclopentyl]acetyl]amino]propanoic acid

(2S)-2-[[2-[(1R,2S)-3-oxo-2-[(Z)-pent-2-enyl]cyclopentyl]acetyl]amino]propanoic acid

C15H23NO4 (281.1627)


   

(2S)-2-[[2-[(1R,2R)-3-oxo-2-[(Z)-pent-2-enyl]cyclopentyl]acetyl]amino]propanoic acid

(2S)-2-[[2-[(1R,2R)-3-oxo-2-[(Z)-pent-2-enyl]cyclopentyl]acetyl]amino]propanoic acid

C15H23NO4 (281.1627)


   

(2S)-2-[[2-[3-oxo-2-[(Z)-pent-2-enyl]cyclopentyl]acetyl]amino]propanoic acid

(2S)-2-[[2-[3-oxo-2-[(Z)-pent-2-enyl]cyclopentyl]acetyl]amino]propanoic acid

C15H23NO4 (281.1627)


   

4-[(2R)-2-[(1R,3R,5S)-3,5-dimethyl-2-oxocyclohexyl]-2-hydroxyethyl]piperidine-2,6-dione

4-[(2R)-2-[(1R,3R,5S)-3,5-dimethyl-2-oxocyclohexyl]-2-hydroxyethyl]piperidine-2,6-dione

C15H23NO4 (281.1627)


   

2-chloro-N-heptyl-N-(3-methylphenyl)acetamide

2-chloro-N-heptyl-N-(3-methylphenyl)acetamide

C16H24ClNO (281.1546)


   

1-Oxo-3-(1-piperidinyl)-5,6,7,8-tetrahydropyrrolo[1,2-a]indole-2-carbonitrile

1-Oxo-3-(1-piperidinyl)-5,6,7,8-tetrahydropyrrolo[1,2-a]indole-2-carbonitrile

C17H19N3O (281.1528)


   
   

Octadec-9-enoate

Octadec-9-enoate

C18H33O2- (281.248)


An octadecenoate in which the double bond is at C-9.

   

1-ethyl-N-[(4-methoxyphenyl)methyl]-5-benzimidazolamine

1-ethyl-N-[(4-methoxyphenyl)methyl]-5-benzimidazolamine

C17H19N3O (281.1528)


   

2-(6-cyano-1-indolyl)-N-cyclohexylacetamide

2-(6-cyano-1-indolyl)-N-cyclohexylacetamide

C17H19N3O (281.1528)


   

2-(2,4-Dimethylanilino)-4-(methoxymethyl)-6-methyl-3-pyridinecarbonitrile

2-(2,4-Dimethylanilino)-4-(methoxymethyl)-6-methyl-3-pyridinecarbonitrile

C17H19N3O (281.1528)


   

(E)-1-[2-(Hydroxymethyl)pyrrolidin-1-yl]-2-methyldec-8-ene-1,3-dione

(E)-1-[2-(Hydroxymethyl)pyrrolidin-1-yl]-2-methyldec-8-ene-1,3-dione

C16H27NO3 (281.1991)


   

Petroselaidate

Petroselaidate

C18H33O2- (281.248)


An unsaturated fatty acid anion resulting from the deprotonation of the carboxy group of petroselaidic acid. The major species at pH 7.3.

   

(13Z)-Octadecenoate

(13Z)-Octadecenoate

C18H33O2- (281.248)


An octadecenoate that is the conjugate base of (13Z)-octadecenoic acid, obtained by deprotonation of the carboxy group; major species at pH 7.3.

   

trans-10-Octadecenoate

trans-10-Octadecenoate

C18H33O2- (281.248)


   

[(1R,2aR,8bR)-2-(3-pyridinylmethyl)-2a,3,4,8b-tetrahydro-1H-azeto[2,3-c]quinolin-1-yl]methanol

[(1R,2aR,8bR)-2-(3-pyridinylmethyl)-2a,3,4,8b-tetrahydro-1H-azeto[2,3-c]quinolin-1-yl]methanol

C17H19N3O (281.1528)


   

[(1S,2aR,8bR)-2-(3-pyridinylmethyl)-2a,3,4,8b-tetrahydro-1H-azeto[2,3-c]quinolin-1-yl]methanol

[(1S,2aR,8bR)-2-(3-pyridinylmethyl)-2a,3,4,8b-tetrahydro-1H-azeto[2,3-c]quinolin-1-yl]methanol

C17H19N3O (281.1528)


   

[(1R,2aS,8bS)-2-(3-pyridinylmethyl)-2a,3,4,8b-tetrahydro-1H-azeto[2,3-c]quinolin-1-yl]methanol

[(1R,2aS,8bS)-2-(3-pyridinylmethyl)-2a,3,4,8b-tetrahydro-1H-azeto[2,3-c]quinolin-1-yl]methanol

C17H19N3O (281.1528)


   

[(1S,2aS,8bS)-2-(3-pyridinylmethyl)-2a,3,4,8b-tetrahydro-1H-azeto[2,3-c]quinolin-1-yl]methanol

[(1S,2aS,8bS)-2-(3-pyridinylmethyl)-2a,3,4,8b-tetrahydro-1H-azeto[2,3-c]quinolin-1-yl]methanol

C17H19N3O (281.1528)


   

Ibogamine(1+)

Ibogamine(1+)

C19H25N2+ (281.2018)


A tertiary ammonium ion resulting from the protonation of the tertiary amino group of ibogamine. It is the major microspecies at pH 7.3.

   

(E,Z)-dicyclopropyl-alpha-mycolate

(E,Z)-dicyclopropyl-alpha-mycolate

C17H29O3- (281.2117)


   

5-[(Cyclohexanecarbonyl)amino]-3-(morpholin-4-yl)-1,2,3-oxadiazol-3-ium

5-[(Cyclohexanecarbonyl)amino]-3-(morpholin-4-yl)-1,2,3-oxadiazol-3-ium

C13H21N4O3+ (281.1614)


   

N-[(4E,8E,12E)-1,3-dihydroxytetradeca-4,8,12-trien-2-yl]acetamide

N-[(4E,8E,12E)-1,3-dihydroxytetradeca-4,8,12-trien-2-yl]acetamide

C16H27NO3 (281.1991)


   

4-(3-(4-(2-Hydroxyethoxy)phenoxy)propyl)morphorine

4-(3-(4-(2-Hydroxyethoxy)phenoxy)propyl)morphorine

C15H23NO4 (281.1627)


   

N-[1-(1-Naphthyl)ethyl]-2,3-dimethyl-4-pentenamide

N-[1-(1-Naphthyl)ethyl]-2,3-dimethyl-4-pentenamide

C19H23NO (281.178)


   

2-(3-Hydroxybutoxy)-N-(2-(ethylamino)ethyl)-3-pyridinecarboxamide

2-(3-Hydroxybutoxy)-N-(2-(ethylamino)ethyl)-3-pyridinecarboxamide

C14H23N3O3 (281.1739)


   

3-(carboxymethyl)-4-[(2E)-6-methylhepta-2,5-dien-2-yl]pyrrolidine-2-carboxylic acid

3-(carboxymethyl)-4-[(2E)-6-methylhepta-2,5-dien-2-yl]pyrrolidine-2-carboxylic acid

C15H23NO4 (281.1627)


   

Terodiline

Terodiline

C20H27N (281.2143)


G - Genito urinary system and sex hormones > G04 - Urologicals > G04B - Urologicals > G04BD - Drugs for urinary frequency and incontinence D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents > D010276 - Parasympatholytics C78281 - Agent Affecting Musculoskeletal System > C29696 - Muscle Relaxant C78272 - Agent Affecting Nervous System > C29698 - Antispasmodic Agent D002317 - Cardiovascular Agents > D002121 - Calcium Channel Blockers D000077264 - Calcium-Regulating Hormones and Agents D049990 - Membrane Transport Modulators

   

Petroselinate

Petroselinate

C18H33O2- (281.248)


An unsaturated fatty acid anion resulting from the deprotonation of the carboxy group of petroselinic acid. The major species at pH 7.3.

   

cis-vaccenate(1-)

cis-vaccenate(1-)

C18H33O2 (281.248)


A vaccenate(1-) that is the conjugate base of cis-vaccenic acid, arising from deprotonation of the carboxylic acid group.

   

4-[2-(3,5-dimethyl-2-oxocyclohexyl)-2-hydroxyethyl]piperidine-2,6-dione

4-[2-(3,5-dimethyl-2-oxocyclohexyl)-2-hydroxyethyl]piperidine-2,6-dione

C15H23NO4 (281.1627)


   

3-{4-[2-Hydroxy-3-(propan-2-ylamino)propoxy]phenyl}propanoic acid

3-{4-[2-Hydroxy-3-(propan-2-ylamino)propoxy]phenyl}propanoic acid

C15H23NO4 (281.1627)


   

Octadecenoate

Octadecenoate

C18H33O2 (281.248)


A fatty acid anion containing 18 carbons and one double bond. Formed by deprotonation of the carboxylic acid group. Major species at pH 7.3.

   

(10E)-octadecenoate

(10E)-octadecenoate

C18H33O2 (281.248)


An octadecenoate that is the conjugate base of (10E)-octadecenoic acid, obtained by deprotonation of the carboxy group; major species at pH 7.3.

   

trans-vaccenate(1-)

trans-vaccenate(1-)

C18H33O2 (281.248)


A vaccenate(1-) having a trans- double bond.

   

vaccenate(1-)

vaccenate(1-)

C18H33O2 (281.248)


A long-chain, unsaturated fatty acid anion and the conjugate base of vaccenic acid, arising from deprotonation of the carboxylic acid group.

   
   

(2e,4e,12z)-1-(piperidin-1-yl)tetradeca-2,4,12-trien-8,10-diyn-1-one

(2e,4e,12z)-1-(piperidin-1-yl)tetradeca-2,4,12-trien-8,10-diyn-1-one

C19H23NO (281.178)


   

(2e,7e,9e)-6,11-dihydroxy-n-(2-methylpropyl)dodeca-2,7,9-trienimidic acid

(2e,7e,9e)-6,11-dihydroxy-n-(2-methylpropyl)dodeca-2,7,9-trienimidic acid

C16H27NO3 (281.1991)


   

2-[(3z)-hex-3-en-1-yl]-1h,2h,3h,4h-pyrido[1,2-a]quinolin-6-one

2-[(3z)-hex-3-en-1-yl]-1h,2h,3h,4h-pyrido[1,2-a]quinolin-6-one

C19H23NO (281.178)


   

1-[2-(hydroxymethyl)pyrrolidin-1-yl]-2-methyldec-6-ene-1,3-dione

1-[2-(hydroxymethyl)pyrrolidin-1-yl]-2-methyldec-6-ene-1,3-dione

C16H27NO3 (281.1991)


   

8-methyl-8-azabicyclo[3.2.1]octan-3-yl nonanoate

8-methyl-8-azabicyclo[3.2.1]octan-3-yl nonanoate

C17H31NO2 (281.2355)


   

(11z)-5-propyl-1-oxa-4-azacyclohexadec-11-en-16-one

(11z)-5-propyl-1-oxa-4-azacyclohexadec-11-en-16-one

C17H31NO2 (281.2355)


   

(3s)-5-[(1e,3s,5s)-3,5-dimethyl-2-oxocyclohexylidene]-3-(c-hydroxycarbonimidoylmethyl)pentanoic acid

(3s)-5-[(1e,3s,5s)-3,5-dimethyl-2-oxocyclohexylidene]-3-(c-hydroxycarbonimidoylmethyl)pentanoic acid

C15H23NO4 (281.1627)


   

acetyllycofawcine

NA

C16H27NO3 (281.1991)


{"Ingredient_id": "HBIN014481","Ingredient_name": "acetyllycofawcine","Alias": "NA","Ingredient_formula": "C16H27NO3","Ingredient_Smile": "CC1CC23C4CCCN2CCCC3(C(C1O)CC4O)O","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "33364","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}

   

(1r,2s,7as)-1-(hept-5-en-1-yl)-1-hydroxy-7a-(hydroxymethyl)-2-methyl-tetrahydropyrrolizin-3-one

(1r,2s,7as)-1-(hept-5-en-1-yl)-1-hydroxy-7a-(hydroxymethyl)-2-methyl-tetrahydropyrrolizin-3-one

C16H27NO3 (281.1991)


   

(2r,6e)-1-[(2r)-2-(hydroxymethyl)pyrrolidin-1-yl]-2-methyldec-6-ene-1,3-dione

(2r,6e)-1-[(2r)-2-(hydroxymethyl)pyrrolidin-1-yl]-2-methyldec-6-ene-1,3-dione

C16H27NO3 (281.1991)


   

2-[2-(3,5-dimethyl-2-oxocyclohexyl)-6-oxooxan-4-yl]ethanimidic acid

2-[2-(3,5-dimethyl-2-oxocyclohexyl)-6-oxooxan-4-yl]ethanimidic acid

C15H23NO4 (281.1627)


   

5-(3,5-dimethyl-2-oxocyclohexylidene)-3-(c-hydroxycarbonimidoylmethyl)pentanoic acid

5-(3,5-dimethyl-2-oxocyclohexylidene)-3-(c-hydroxycarbonimidoylmethyl)pentanoic acid

C15H23NO4 (281.1627)


   

2-[(2r,4s)-2-[(3s,5s)-3,5-dimethyl-2-oxocyclohexyl]-6-oxooxan-4-yl]ethanimidic acid

2-[(2r,4s)-2-[(3s,5s)-3,5-dimethyl-2-oxocyclohexyl]-6-oxooxan-4-yl]ethanimidic acid

C15H23NO4 (281.1627)


   

(6s,8as,9s,11s,12ar)-4,6-dihydroxy-9,11-dimethyl-1,5,6,7,8,8a,9,10,11,12a-decahydro-3-benzazecine-2,12-dione

(6s,8as,9s,11s,12ar)-4,6-dihydroxy-9,11-dimethyl-1,5,6,7,8,8a,9,10,11,12a-decahydro-3-benzazecine-2,12-dione

C15H23NO4 (281.1627)


   

2-[(2r,4s)-2-[(1s,3s,5s)-3,5-dimethyl-2-oxocyclohexyl]-6-oxooxan-4-yl]ethanimidic acid

2-[(2r,4s)-2-[(1s,3s,5s)-3,5-dimethyl-2-oxocyclohexyl]-6-oxooxan-4-yl]ethanimidic acid

C15H23NO4 (281.1627)


   

4,6-dihydroxy-9,11-dimethyl-1,5,6,7,8,8a,9,10,11,12a-decahydro-3-benzazecine-2,12-dione

4,6-dihydroxy-9,11-dimethyl-1,5,6,7,8,8a,9,10,11,12a-decahydro-3-benzazecine-2,12-dione

C15H23NO4 (281.1627)


   

(2e,4e,9e)-8,11-dihydroxy-n-(2-methylpropyl)dodeca-2,4,9-trienimidic acid

(2e,4e,9e)-8,11-dihydroxy-n-(2-methylpropyl)dodeca-2,4,9-trienimidic acid

C16H27NO3 (281.1991)


   

1-[2-(hydroxymethyl)pyrrolidin-1-yl]-2-methyldec-8-ene-1,3-dione

1-[2-(hydroxymethyl)pyrrolidin-1-yl]-2-methyldec-8-ene-1,3-dione

C16H27NO3 (281.1991)


   

2-[(2e)-3,7-dimethylocta-2,6-dien-1-yl]-1h-quinolin-4-one

2-[(2e)-3,7-dimethylocta-2,6-dien-1-yl]-1h-quinolin-4-one

C19H23NO (281.178)


   

n-(4-{9h-pyrido[3,4-b]indol-1-yl}butyl)guanidine

n-(4-{9h-pyrido[3,4-b]indol-1-yl}butyl)guanidine

C16H19N5 (281.164)


   

(2e,6e,8e)-10-hydroxy-n-(2-hydroxy-2-methylpropyl)-5-oxoundeca-2,6,8-trienimidic acid

(2e,6e,8e)-10-hydroxy-n-(2-hydroxy-2-methylpropyl)-5-oxoundeca-2,6,8-trienimidic acid

C15H23NO4 (281.1627)


   

(2r,8e)-1-[(2r)-2-(hydroxymethyl)pyrrolidin-1-yl]-2-methyldec-8-ene-1,3-dione

(2r,8e)-1-[(2r)-2-(hydroxymethyl)pyrrolidin-1-yl]-2-methyldec-8-ene-1,3-dione

C16H27NO3 (281.1991)


   

4-[(2r)-2-[(1r,3r,5s)-3,5-dimethyl-2-oxocyclohexyl]-2-hydroxyethyl]-6-hydroxy-4,5-dihydro-3h-pyridin-2-one

4-[(2r)-2-[(1r,3r,5s)-3,5-dimethyl-2-oxocyclohexyl]-2-hydroxyethyl]-6-hydroxy-4,5-dihydro-3h-pyridin-2-one

C15H23NO4 (281.1627)


   

(6e)-1-[(2r)-2-(hydroxymethyl)pyrrolidin-1-yl]-2-methyldec-6-ene-1,3-dione

(6e)-1-[(2r)-2-(hydroxymethyl)pyrrolidin-1-yl]-2-methyldec-6-ene-1,3-dione

C16H27NO3 (281.1991)


   

2-(3,7-dimethylocta-2,6-dien-1-yl)-1h-quinolin-4-one

2-(3,7-dimethylocta-2,6-dien-1-yl)-1h-quinolin-4-one

C19H23NO (281.178)


   

(1r,3s,5s,6r)-6-(acetyloxy)-8-methyl-8-azabicyclo[3.2.1]octan-3-yl (2e)-2-methylbut-2-enoate

(1r,3s,5s,6r)-6-(acetyloxy)-8-methyl-8-azabicyclo[3.2.1]octan-3-yl (2e)-2-methylbut-2-enoate

C15H23NO4 (281.1627)


   

1-(hept-5-en-1-yl)-1-hydroxy-7a-(hydroxymethyl)-2-methyl-tetrahydropyrrolizin-3-one

1-(hept-5-en-1-yl)-1-hydroxy-7a-(hydroxymethyl)-2-methyl-tetrahydropyrrolizin-3-one

C16H27NO3 (281.1991)


   

4-[(2r)-2-[(1s,3r,5s)-3,5-dimethyl-2-oxocyclohexyl]-2-hydroxyethyl]-6-hydroxy-4,5-dihydro-3h-pyridin-2-one

4-[(2r)-2-[(1s,3r,5s)-3,5-dimethyl-2-oxocyclohexyl]-2-hydroxyethyl]-6-hydroxy-4,5-dihydro-3h-pyridin-2-one

C15H23NO4 (281.1627)


   

4-[(2r)-2-[(1r,3s,5s)-3,5-dimethyl-2-oxocyclohexyl]-2-hydroxyethyl]-6-hydroxy-4,5-dihydro-3h-pyridin-2-one

4-[(2r)-2-[(1r,3s,5s)-3,5-dimethyl-2-oxocyclohexyl]-2-hydroxyethyl]-6-hydroxy-4,5-dihydro-3h-pyridin-2-one

C15H23NO4 (281.1627)


   

4-[2-(3,5-dimethyl-2-oxocyclohexyl)-2-hydroxyethyl]-6-hydroxy-4,5-dihydro-3h-pyridin-2-one

4-[2-(3,5-dimethyl-2-oxocyclohexyl)-2-hydroxyethyl]-6-hydroxy-4,5-dihydro-3h-pyridin-2-one

C15H23NO4 (281.1627)


   

(2e,4e,6e,12z)-n-(3-methylbutyl)tetradeca-2,4,6,12-tetraen-8,10-diynimidic acid

(2e,4e,6e,12z)-n-(3-methylbutyl)tetradeca-2,4,6,12-tetraen-8,10-diynimidic acid

C19H23NO (281.178)


   

(2e,4e,12e)-1-(piperidin-1-yl)tetradeca-2,4,12-trien-8,10-diyn-1-one

(2e,4e,12e)-1-(piperidin-1-yl)tetradeca-2,4,12-trien-8,10-diyn-1-one

C19H23NO (281.178)


   

(1r,3s,5s)-8-methyl-8-azabicyclo[3.2.1]octan-3-yl nonanoate

(1r,3s,5s)-8-methyl-8-azabicyclo[3.2.1]octan-3-yl nonanoate

C17H31NO2 (281.2355)


   

(2e,4e,6z,12z)-n-(3-methylbutyl)tetradeca-2,4,6,12-tetraen-8,10-diynimidic acid

(2e,4e,6z,12z)-n-(3-methylbutyl)tetradeca-2,4,6,12-tetraen-8,10-diynimidic acid

C19H23NO (281.178)


   

1-(piperidin-1-yl)tetradeca-2,4,12-trien-8,10-diyn-1-one

1-(piperidin-1-yl)tetradeca-2,4,12-trien-8,10-diyn-1-one

C19H23NO (281.178)